AcquisitionOther
Tonix Pharmaceuticals Holding Corp. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Tonix Pharmaceuticals Holding Corp. -> target · $23 million
Zembrace SymTouch is the only actively promoted brand of sumatriptan autoinjector in the United States (other sumatriptan autoinjector products on the market are Imitrex® and generics to Imitrex®).
Open source record (SEC) ↗